Efficacy and safety of tacrolimus ointment 0.03% treatment in a 1-month-old "red baby": A case report

Allergy and Asthma Proceedings

Volumn 27, Issue 6, 2006, Pages 523-526

  Leonardi, Salvatore ^a,b   Rotolo, Novella ^a,b   Marchese, Giuseppe ^a,b   La Rosa, Mario ^a,b  

^a University of Catania ^*  (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; CASE REPORT; HUMAN; INFANT; MALE; NEWBORN EXFOLIATIVE DERMATITIS; OINTMENT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; DERMATITIS, EXFOLIATIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; OINTMENTS; TACROLIMUS;

EID: 33845510120     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2897     Document Type: Article

References (14)

1. Skaehill PA. Tacrolimus in dermatologic disorders. Ann Pharmacother 35:582-588, 2001.
2. Assmann T, Homey B, and Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin Pharmacother 2:116775, 2001.
3. Carroll CL, and Fleischer AB Jr. Tacrolimus ointment: The treatment of atopic dermatitis and other inflammatory cutaneous disease. Expert Opin Pharmacother 5:2127-2137, 2004.
4. Fonacier L, Spergel J, Charlesworth EN, et al. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 115:1249-1253, 2005.
5. Burton JL. Eczema, lichenification, prurigo, and erythroderma. In Rook/Wilkinson/Ebling Textbook of Dermatology, 5th ed., Champion RH, Urton JL, and Ebling FIG (Eds). Oxford: Blackwell Scientific publications, 537-588, 1992.
6. Leiner C. Uber erythrodermia desquamativa, eine eigenartige universelle Dermatose der Brustkinder. Arch Dermatol Syphilol 89:163-189, 1908.
7. Sigurdson V, Toonstra J, Hezemans-Boer M, et al. Erythroderma. A clinical and follow up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 35:53-57, 1996.
8. Pruszkowski A, Bodemer C, Fraitag S, et al. Neonatal and infantile erythrodermas: A retrospective study of 51 patients. Arch Dermatol 136:875-880, 2000.
9. Sarkar R, Basu S, and Sharma RC. Neonatal and infantile erythrodermas. Arch Dermatol 137:822-823, 2001.
10. Hoeger PH, and Harper JI. Neonatal erythroderma: Differential diagnosis and management of the "red baby." Arch Dis Child 79:186-191, 1998.
11. Paller A, Eichenfield LF, Leung DYM, et al. Tacrolimus ointment study group. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in paediatric patients. J Am Acad Dermatol 44:s47-s57, 2001.
12. Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137:747-750, 2001.
13. Bens G, Boralevi F, Buzenet C, et al. Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. Br J Dermatol 149:224-226, 2003.
14. Ashcroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. BMJ 330:516, 2005.